Posts

Posted on

Shareholders of Virginia National Bankshares Corporation and Fauquier Bankshares, Inc. Approve Merger

CHARLOTTESVILLE, Va. and WARRENTON, Va., March 26, 2021 (GLOBE NEWSWIRE) — At separate shareholder meetings yesterday, shareholders of both Virginia National Bankshares Corporation (OTCQX: VABK) (“Virginia National”), the parent holding company of Virginia National Bank (the “Bank”), and Fauquier Bankshares, Inc. (NASDAQ: FBSS) (“Fauquier”), the parent holding company of The Fauquier Bank, approved the previously announced merger of Fauquier into Virginia National (the “Merger”). The parties expect the Merger to be effective on April 1, 2021.

Based on financial information as of December 31, 2020, the combined company would have approximately $1.7 billion in assets, $1.5 billion in deposits, $1.2 billion in loans and $1.1 billion in assets under management.

About Virginia National

Virginia National, headquartered in Charlottesville, Virginia, is the bank holding company for Virginia National Bank. The Bank has four banking offices in Charlottesville and one in Winchester, and offers loan, deposit and treasury management services in Richmond, Virginia. The Bank has entered into a lease for branch and office space in Richmond, Virginia and plans to open the office in the second quarter of 2021. Virginia National Bank offers a full range of banking and related financial services to meet the needs of individuals, businesses and charitable organizations, including fiduciary, trust and estate administration services under the name VNB Trust and Estate Services, and wealth and investment advisory services, including financial planning, under the name Sturman Wealth Advisors. Investment management services are also offered through Masonry Capital Management, LLC, a registered investment advisor and wholly-owned subsidiary of Virginia National. Virginia National’s stock trades on the OTC Markets Group’s OTCQX Market under the symbol “VABK.” Additional information about Virginia National is also available at www.vnbcorp.com.

About Fauquier

Fauquier Bankshares, Inc. and its principal subsidiary, The Fauquier Bank, had combined assets of $867.2 million and total shareholders’ equity of $72.5 million at December 31, 2020. The Fauquier Bank is an independent community bank offering a full range of financial services, including internet banking, mobile banking, commercial, retail, insurance, wealth management, and financial planning services through eleven banking offices throughout Fauquier and Prince William counties in Virginia. Additional information about Fauquier is available at www.TFB.bank or by calling: (800) 638-3798.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by words such as “may,” “assumes,” “approximately,” “will,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “targets,” “projects,” or words of similar meaning. These forward-looking statements are based upon the current beliefs and expectations of the respective management of Virginia National and Fauquier and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the control of Virginia National and Fauquier. In addition, these forward-looking statements are subject to various risks, uncertainties and assumptions with respect to future business strategies and decisions that are subject to change and difficult to predict with regard to timing, extent, likelihood and degree of occurrence. As a result, actual results may differ materially from the anticipated results discussed in these forward-looking statements because of possible uncertainties.

The following factors, among others, could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: (1) the businesses of Virginia National and Fauquier may not be combined successfully, or such combination may take longer, be more difficult, time-consuming or costly to accomplish than expected; (2) the expected growth opportunities or cost savings from the Merger may not be fully realized or may take longer to realize than expected; (3) deposit attrition, operating costs, customer losses and business disruption following the Merger, including adverse effects on relationships with employees and customers, may be greater than expected; (4) economic, legislative or regulatory changes, including changes in accounting standards, may adversely affect the businesses in which Virginia National and Fauquier are engaged; (5) the interest rate environment may further compress margins and adversely affect net interest income; (6) results may be adversely affected by continued adverse changes to credit quality; (7) competition from other financial services companies in Virginia National’s and Fauquier’s markets could adversely affect operations; (8) an economic slowdown could adversely affect credit quality and loan originations; (9) the COVID-19 pandemic is adversely affecting Virginia National, Fauquier, and their respective customers, employees and third-party service providers; the adverse impacts of the pandemic on their respective business, financial position, operations and prospects have been material, and it is not possible to accurately predict the extent, severity or duration of the pandemic or when normal economic and operation conditions will return; and (10) other factors that may affect future results of Virginia National and Fauquier. Additional factors, that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in Virginia National’s and Fauquier’s reports (such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) filed with the Securities and Exchange Commission (the “SEC”) and available on the SEC’s Internet site (http://www.sec.gov).

Contacts:
Virginia National Bankshares Corporation
Glenn Rust, President and Chief Executive Officer
(434) 817-8649

Fauquier Bankshares, Inc.
Marc Bogan, President and Chief Executive Officer
(540) 347-6742



Posted on

TFF Pharmaceuticals Prices Offering of Common Stock

TFF Pharmaceuticals Prices Offering of Common Stock

AUSTIN, Texas–(BUSINESS WIRE)–
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (“TFF”) technology platform, today announced that it has priced an underwritten offering of 2,855,000 shares of its common stock, 2,140,000 shares of which are to be sold by the Company and 715,000 shares of which are to be sold by Lung Therapeutics, Inc. (“Selling Stockholder”), at an offering price of $14.00 per share. TFFP expects the aggregate gross proceeds from this offering to be approximately $40 million, before deducting the underwriting discount and commissions and other estimated offering expenses, of which approximately $10 million of the gross proceeds will be received by the Selling Stockholder. TFFP expects to close the offering, subject to customary conditions, on or about March 30, 2021.

TFFP intends to use the net proceeds from the proposed offering for working capital and general corporate purposes.

Roth Capital Partners acted as sole book-running manager for the offering.

The offering of common stock was made pursuant to TFF Pharmaceuticals’ shelf registration statement filed with the Securities and Exchange Commission (“SEC”) and declared effective. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

A preliminary prospectus supplement has been filed with the SEC and a final prospectus supplement will be filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to the securities being offered may be obtained, when available, from Roth Capital Partners, LLC. 888 San Clemente Drive, Newport Beach, CA 92660, Attention: Prospectus Department, by telephone at (800) 678-9147 or by email at [email protected]. Electronic copies of the final prospectus supplement and accompanying prospectus will also be available on the SEC’s website at http://www.sec.gov.

About TFF Pharmaceuticals

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.

Safe Harbor

This press release contains forward-looking statements regarding the expected closing of the underwritten offering and the intended use of proceeds from the offering. The offering is subject to customary closing conditions and there can be no assurance as to whether or when the offering may be completed. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially, including those risks disclosed under the caption “Risk Factors” in the preliminary prospectus supplement related to the offering. TFF Pharmaceuticals cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Company:

Glenn Mattes

President and CEO

TFF Pharmaceuticals, Inc

[email protected]

737-802-1973

Kirk Coleman

Chief Financial Officer

TFF Pharmaceuticals, Inc.

[email protected]

817-989-6358

Investor Relations and Media:

Paul Sagan

LaVoieHealthScience

[email protected]

617-865-0041

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Other Health

MEDIA:

Logo
Logo
Posted on

Ancora Issues Important Letter to Blucora Stockholders

Ancora Issues Important Letter to Blucora Stockholders

Encourages Stockholders to Avoid Being Misled by Any Reactionary Promises Made by Blucora Regarding a Fresh Strategy and New Synergy Targets

Highlights Years of Company Statements Pertaining to the Pursuit of Elusive Synergies

Questions Whether the Board and Management are Economically Incentivized to Maintain a Bigger, Bloated Holding Company Model Rather Than a Focused, Streamlined Business

Urges Stockholders to Visit www.ABetterBlucora.com and Vote on the WHITE Proxy Card to Elect Ancora’s Four-Member Slate

CLEVELAND–(BUSINESS WIRE)–
Ancora Holdings, Inc. (together with its affiliates, “Ancora”), which collectively with the other participants in its solicitation beneficially owns approximately 3.4% of the outstanding common stock of Blucora, Inc. (NASDAQ: BCOR) (“Blucora” or the “Company”), today issued the below letter to stockholders regarding the Company’s ineffective strategy during the six-year directorship and 14-month executive tenure of Chief Executive Officer Chris Walters.

As a reminder, Ancora is seeking to elect Frederick D. DiSanto, Cindy Schulze Flynn, Robert D. MacKinlay and Kimberly Smith Spacek to Blucora’s ten-member Board of Directors at the Company’s Annual Meeting of Stockholders on April 21, 2021. Ancora urges Blucora’s stockholders and stakeholders to visit www.ABetterBlucora.com to obtain important information, including instructions for how to vote on the WHITE Proxy Card to elect our four-member slate.

***

March 26, 2021

Fellow Stockholders,

Ancora Holdings, Inc. (together with its affiliates, “Ancora”) anticipates that you will soon begin to hear a great deal from Blucora, Inc. (“Blucora” or the “Company”) and its Board of Directors (the “Board”) about the viability of management’s new strategy. We expect Blucora’s high-priced external advisors will produce a presentation or whitepaper that lays out anticipated synergies and strategic targets that support the incumbents’ preferred path forward. Furthermore, we suspect the Company will paint a rosy picture of enduring value creation that is just over the horizon – all while wrongfully accusing Ancora of being a short-term investor and minimizing our director candidates’ strong, relevant expertise. We encourage you to see through this type of smokescreen and focus on the facts.

As this election contest plays out, it is becoming increasingly clear to us that the Board will do and say just about anything to keep Ancora’s minority slate of director candidates out of the boardroom. Since Ancora has no interest in delving into the proverbial gutter, we are refraining from opening up a debate right now about the incumbents’ scorched-earth tactics. We simply want stockholders to focus on whether our four director candidates have the professional qualifications to help this seemingly insular Board develop a credible long-term strategy and install a culture of accountability, incentivization and integrity.

It is important to reiterate once again that Ancora was forced to initiate an election contest at Blucora. Although we spent much of the past winter trying to have a productive private dialogue with leadership, our concerns regarding the Company’s perpetually elusive synergies and ineffective, six-year-old strategy were dismissed. No independent member of the Board even joined in the discussions and no good faith resolution was ever proposed. Once we recognized that the Company’s leaders were either unwilling or unable to address the challenges at hand, including the alarming exodus of Avantax financial professionals, we had no choice other than to pursue boardroom change.

WE URGE STOCKHOLDERS TO AVOID BEING MISLED BY BLUCORA’S PROMISE OF A NEW STRATEGY

For several years, Blucora has been focused on the same wealth management and tax preparation business model it now calls new:

  • In October 2015, when current Chief Executive Officer Chris Walters and incumbent director Mary Zappone were on the Board, the Company called its acquisition of HD Vest Financial Services a “[t]ransformative acquisition that is attractive, synergistic with TaxACT and consistent with our stated strategy.”1

  • In March 2016, when Mr. Walters and Ms. Zappone were on the Board, former Chief Executive Officer John Clendening noted “the unique strengths and synergy opportunities of [the Company’s] two businesses.”2
  • In February 2017, when Mr. Walters and Ms. Zappone were on the Board, former Chief Executive Officer John Clendening labeled the Company “a simplified, streamlined and synergistic business.”3
  • In October 2017, when Mr. Walters and a majority of the directors Ancora is seeking to remove were on the Board, leadership claimed to have conducted a “comprehensive strategic planning process” and “outlined the near-term objectives that will allow us to best leverage our unique business model.”4
  • In October 2018, when Mr. Walters and all four of the directors Ancora is seeking to remove were on the Board, leadership said the Company was “well positioned to continue our growth trajectory as we transform these two great companies for our customers and continue to challenge the industry with tax-smart innovation.”5
  • In January 2020, when Mr. Walters and all four of the directors Ancora is seeking to remove were on the Board, leadership noted the acquisition of HK Financial Services “reinforces Blucora’s strategy of delivering tax-advantaged wealth management solutions to advisors and end-clients.”6
  • During the second quarter earnings call for fiscal year 2020, Mr. Walters reinforced “we have locked in on our strategy” and “[t]here aren’t further refinements in the strategy to come.”7

It should be abundantly clear that the Board and Mr. Walters have had ample time – over several years – to make their strategy work. Unfortunately, Blucora’s negative returns and long-term underperformance relative to various peers reinforce that pairing a wealth management business and a TurboTax-like preparation business is very likely the wrong strategy. We firmly believe this is why Avantax financial professionals continue to flee and TaxAct filings stagnated well prior to the COVID-19 pandemic. To put an even finer point on our position, Blucora’s stock is down nearly 35% since the “comprehensive strategic planning process” that took place three-and-a-half years ago – a period in which Steven Aldrich, Georganne Proctor, Mr. Walters and Ms. Zappone were on the Board.8

In our view, stockholders need to take into account the Company’s past statements and this important historical context when considering any new pledges. Stockholders should also question whether pairing Avantax and TaxAct is simply a byproduct of the Board rushing to utilize the Company’s Net Operating Loss benefits. That would be an unacceptable rationale.

WE URGE STOCKHOLDERS TO CONSIDER WHY THE BOARD AND MR. WALTERS MAY BE COMMITTED TO A FLAWED STRATEGY

Ancora is extremely concerned that the Board may be incentivized to continue pursuing a strategy that supports excessive corporate overhead and justifies inflated compensation for leadership. In 2020, Blucora’s eight independent Board members received approximately $2 million dollars in compensation, which we deem an excessive sum for a floundering small cap entity that suffered sizable stock price declines for the year. We question why Blucora’s annual director fees are meaningfully higher than larger peers, such as Focus Financial Partners (NASDAQ: FOCS) and Waddell & Reed Financial (NYSE: WDR), who have outperformed the Company and found paths to delivering positive returns for stockholders over multiple horizons.

We are equally concerned by Mr. Walters’ apparent misalignment with stockholders. Not only did Mr. Walters earn an astounding $8.1 million during the height of the pandemic in 2020, but he was paid far more than his predecessor and the vast majority of peers (including the Chief Executive Officers at high-performing companies). From our vantage point, he appears highly-incentivized to maintain a bigger, bloated Blucora rather than a focused, streamlined Company. Please see below: 

Company

Current Market Cap

Compensation for

Chief Executive*

Stockholder Return

Under Chief

Executive**

Blucora

~$780 Million

$8,157,442

(29%)

 

Wealth

Peers

 

BrightSphere

Investment Group, Inc.

~$1.54 Billion

$3,332,200

(or ~59% less than Mr.

Walters)

94.65%

Envestnet, Inc.

~$3.97 Billion

$4,104,970

(or ~50% less than Mr.

Walters)

46.53%

Focus Financial

Partners, Inc.

~$3.17 Billion

$6,814,831

(or ~17% less than Mr.

Walters)

15.55%

Virtus Investment

Partners, Inc.

~$1.78 Billion

$7,314,000

(or ~10% less than Mr.

Walters)

1,966.67%

Waddell & Reed

Financial, Inc.

~$1.56 Billion

$1,926,810

(or ~76% less than Mr.

Walters)

87.37%

 

Tax

Peers

 

H&R Block, Inc.

~$3.73 Billion

$6,921,199

(or ~15% less than Mr.

Walters)

23.44%

Intuit Inc.

~$101.98 Billion

$20,324,211

(or 149% more than Mr.

Walters)

98.37%

Source: Bloomberg; company filings via the U.S. Securities and Exchange Commission.

* Reflects total Chief Executive Officer compensation for the past full fiscal year disclosed by each company as of March 25, 2021.

** Total return calculations begin on the date of the Chief Executive Officer’s appointment and run through December 31, 2020.

In addition, Mr. Walters earned more compensation in 2020 than LPL Financial Chief Executive Officer Dan Arnold. We contend that investors familiar with the wealth management sector will be confounded by the fact that Mr. Walters received nearly 10% more in compensation than the leader of LPL Financial, a successful company with a current market capitalization that is more than 11x the size of Blucora. We question why Mr. Arnold was able to accept a pay reduction in 2020, but Mr. Walters received compensation in excess of his predecessor and most of his peers.

WE URGE STOCKHOLDERS TO VOTE TO REFRESH THE BOARD WITH QUALIFIED FINANCIAL SERVICES EXPERTS CAPABLE OF OBJECTIVELY ASSESSING BLUCORA’S STRATEGY

In advance of Blucora trying to re-write history and repackage an old strategy in a new wrapper, we believe stockholders should take into account the Company’s past statements and leadership’s compensation structure. We also feel stockholders should take note of the fact that we are not aware of any other public company board of directors that has tried to tie a strategy to a business-to-business wealth management division and a consumer-oriented tax software division.

We feel any attempts by Blucora to rush out fresh details on prospective synergies during this election contest – after we requested this information months ago – should be viewed for what it is: a reactionary ploy. If the Board and Mr. Walters want to turn over a new leaf and restore stockholder confidence, they should immediately reengage with us to present a credible, consensual resolution framework and subsequently undertake a strategic review of the TaxAct business. We firmly believe that failing to take these steps will put long-term value at risk and further undermine the seemingly fractured relationship between Blucora and disillusioned Avantax financial professionals.

Once again, we thank you for your feedback and ongoing engagement with Ancora and its nominees in recent weeks. Although the Company is trying to turn this into a low-road contest, please trust that our director candidates will put this campaign behind them and work collegially with the incumbents upon entering the boardroom. We hope the prospect of help being on the way is a welcomed sign to all of Blucora’s stakeholders.

Sincerely,

Frederick D. DiSanto

Chairman and Chief Executive Officer

Ancora Holdings, Inc.

***

About Ancora

Ancora Holdings, Inc. is an employee owned, Cleveland, Ohio based holding company which wholly owns four separate and distinct SEC Registered Investment Advisers and a broker dealer. Ancora Advisors LLC specializes in customized portfolio management for individual investors, high net worth investors, investment companies (mutual funds), and institutions such as pension/profit sharing plans, corporations, charitable & “Not-for Profit” organizations, and unions. Ancora Family Wealth Advisors, LLC is a leading, regional investment and wealth advisor managing assets on behalf families and high net-worth individuals. Ancora Alternatives LLC specializes in pooled investments (hedge funds/investment limited partnerships). Ancora Retirement Plan Advisors, Inc. specializes in providing non-discretionary investment guidance for small and midsize employer sponsored retirement plans. Inverness Securities, LLC is a FINRA registered Broker Dealer.

__________________________

1 Company filing/presentation dated October 14, 2015. Emphasis added by Ancora.

2 Company filing/press release dated March 15, 2016. Emphasis added by Ancora.

3 Company filing/press release dated February 16, 2017. Emphasis added by Ancora.

4 Company filing/press release dated October 26, 2017. Emphasis added by Ancora.

5 Company filing/press release dated October 31, 2018. Emphasis added by Ancora.

6 Company filing/press release dated January 7, 2020. Emphasis added by Ancora.

7 Company earnings call on August 5, 2020. Emphasis added by Ancora.

8 Reflects the period of October 26, 2017 through December 31, 2020.

For Investors:

Ancora Alternatives

James Chadwick

(216) 593-5048

[email protected]

Saratoga Proxy Consulting LLC

John Ferguson / Joe Mills, 212-257-1311

[email protected] / [email protected]

For Media:

Profile

Greg Marose / Charlotte Kiaie, 347-343-2999

[email protected] / [email protected]

KEYWORDS: Ohio United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Posted on

Prudential Financial releases first Environmental, Social and Governance (ESG) Summary Report

Prudential Financial releases first Environmental, Social and Governance (ESG) Summary Report

Report details newly disclosed EEO-1 and pay equity data

NEWARK, N.J.–(BUSINESS WIRE)–
Prudential Financial, Inc. (NYSE: PRU) has released an Environmental, Social and Governance (ESG) Summary Report, which highlights sustainable actions by the company related to its environmental footprint, diversity and inclusion, talent and governance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210326005088/en/

Our Commitment to Transparency: Representation Data (Graphic: Business Wire)

Our Commitment to Transparency: Representation Data (Graphic: Business Wire)

The report, published alongside Prudential’s 2020 Annual Report and Proxy Statement, includes newly released representation and pay equity data, which detail the composition of the company’s U.S. workforce by race, ethnicity and gender, as well as corresponding compensation metrics.

“This ESG Summary Report underscores the importance of a robust reporting framework to fulfill our company’s purpose of solving the financial challenges of our changing world,” said Margaret “Peggy” Foran, chief governance officer and corporate secretary for Prudential Financial.“Additional transparency provides investors, employees, customers and communities with the ability to even more clearly gauge Prudential’s progress toward our goal of being a sustainable and fully inclusive company.”

The ESG Summary Report includes enhanced disclosures around:

  • The status of the operational and investment targets set by Prudential’s Global Environmental Commitment.
  • The makeup of Prudential’s U.S. workforce by race, ethnicity and gender by job category, including both representation and pay equity data.
  • Actions associated with the company’s nine commitments to racial equity, which will serve as a baseline against which to measure the company’s progress going forward.
  • How the company is tying executive compensation to the achievement of inclusion and diversity performance targets.

Prudential’s ESG Summary Report was created as a supplement to other disclosures available on Prudential’s website, including the company’s annual Sustainability Report, published each June, which provides details about Prudential’s ESG strategy, framework and performance.

About Prudential Financial

Prudential Financial, Inc. (NYSE: PRU), a financial wellness leader and premier active global investment manager with more than $1.5 trillion in assets under management as of Dec. 31, 2020, has operations in the United States, Asia, Europe, and Latin America. Prudential’s diverse and talented employees help to make lives better by creating financial opportunity for more people. Prudential’s iconic Rock symbol has stood for strength, stability, expertise and innovation for more than a century. For more information, please visit news.prudential.com.

MEDIA:

Julie Laskin, (973) 802-3975, [email protected]

Bill Launder, (973) 802-8760, [email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Finance Environment Professional Services Insurance Human Resources

MEDIA:

Logo
Logo
Photo
Photo
Our Commitment to Transparency: Representation Data (Graphic: Business Wire)
Posted on

JBG SMITH Commences Construction at 1900 Crystal Drive

JBG SMITH Commences Construction at 1900 Crystal Drive

Development Will Bring More Than 800 Apartments and New Community Amenities to National Landing

BETHESDA, Md.–(BUSINESS WIRE)–
JBG SMITH (NYSE: JBGS), a leading owner and developer of high-quality, mixed-use properties in the Washington, DC market, announced today the commencement of construction for two residential towers at 1900 Crystal Drive in National Landing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210326005081/en/

Illustrative rendering of 1900 Crystal Drive (Photo: Business Wire)

Illustrative rendering of 1900 Crystal Drive (Photo: Business Wire)

The development at 1900 Crystal Drive is planned to encompass 808 multifamily rental units and approximately 40,000 square feet of street-level retail across two new mixed-use buildings. A 27-story southern tower will feature 471 apartments, while the 26-story northern tower will incorporate 337 apartments. JBG SMITH successfully bid and secured a guaranteed maximum price contract for the project that is more than 7.5% below pre-pandemic pricing.

At approximately 300 feet tall, the buildings, designed by renowned architect COOKFOX in collaboration with Torti Gallas + Partners, will be a striking addition to the National Landing skyline. In addition to a private rooftop and green spaces for residents, JBG SMITH has conceptualized a new retail-served pedestrian-friendly street, which will serve as an activated connection between 18th and 20th Streets.

JBG SMITH is also including a number of neighborhood-oriented improvements that will benefit the entire community. These improvements include enhanced streetscapes, a grand staircase connecting to public open space, public bike facilities, and more.

In 2018, National Landing was chosen for Amazon’s new headquarters, and JBG SMITH was named the developer, leasing agent, and property manager for the project. Amazon is expected to hire 38,000 or more employees in National Landing and is already occupying space at several JBG SMITH-owned commercial assets. Amazon’s growing presence in National Landing is expected to increase the daytime population in the submarket from approximately 50,000 people today to nearly 90,000 people in the future. This would represent a dramatic increase of more than 70%, based on data from the National Landing Business Improvement District.

“The start of construction on 1900 Crystal Drive marks yet another major milestone in National Landing’s ongoing transformation,” said Anthony Greenberg, Executive Vice President of Development at JBG SMITH. “The introduction of new residences, restaurants and shops at 1900 Crystal Drive, combined with our recently delivered retail and entertainment district just about a block away will more than double the concentration of street-facing retail amenities on Crystal Drive. The thriving, mixed-use environment will allow people to easily walk from their home or office to their favorite restaurants and amenities – cementing National Landing as a destination both day and night.”

About JBG SMITH

JBG SMITH is an S&P 400 company that owns, operates, invests in and develops a dynamic portfolio of high-growth mixed-use properties in and around Washington, DC. Through an intense focus on placemaking, JBG SMITH cultivates vibrant, amenity-rich, walkable neighborhoods throughout the Capital region, including National Landing where it serves as the exclusive developer for Amazon’s new headquarters. JBG SMITH’s portfolio currently comprises 16.7 million square feet of high-growth office, multifamily and retail assets at share, 98% at share of which are Metro-served. It also maintains a development pipeline encompassing 17.6 million square feet of mixed-use development opportunities. For more information on JBG SMITH please visit www.jbgsmith.com.

Forward-Looking Statements

Certain statements contained herein may constitute “forward-looking statements” as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not guarantees of performance. They represent our intentions, plans, expectations and beliefs and are subject to numerous assumptions, risks and uncertainties. Consequently, the future results of JBG SMITH Properties (“JBG SMITH” or the “Company”) may differ materially from those expressed in these forward-looking statements. You can find many of these statements by looking for words such as “approximate”, “believes,” “expects,” “anticipates,” “intends,” “plans,” “proposed,” “would,” “may,” or similar expressions in this press release. We also note the following forward-looking statements: estimated square feet, number of apartments and construction commencement date for 1900 Crystal Drive, as well as expected number of jobs and daytime population in National Landing. Many of the factors that will determine the outcome of these and our other forward-looking statements and plans are beyond our ability to control or predict. These factors include, among others: adverse economic conditions in the Washington, DC metropolitan area, the timing of and costs associated with development and property improvements, financing commitments, and general competitive factors. For further discussion of factors that could materially affect the outcome of our forward-looking statements and other risks and uncertainties, see “Risk Factors” and the Cautionary Statement Concerning Forward-Looking Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and other periodic reports the Company files with the Securities and Exchange Commission. For these statements, we claim the protection of the safe harbor for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on our forward-looking statements. All subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements after the date hereof.

Bud Perrone

Rubenstein

Managing Director

(212) 843-8068

[email protected]

Samantha Schmieder

JBG SMITH

Corporate Communications Senior Analyst

(240) 333-7706

[email protected]

KEYWORDS: United States North America District of Columbia Maryland

INDUSTRY KEYWORDS: Residential Building & Real Estate Commercial Building & Real Estate Construction & Property

MEDIA:

Photo
Photo
Illustrative rendering of 1900 Crystal Drive (Photo: Business Wire)
Posted on

CrowdStrike to Host Investor Briefing

CrowdStrike to Host Investor Briefing

SUNNYVALE, Calif.–(BUSINESS WIRE)–
CrowdStrike Holdings, Inc. (Nasdaq: CRWD), today announced that it will host a briefing for investors on April 8, 2021. During the session, George Kurtz, co-founder and chief executive officer, and Burt Podbere, chief financial officer, will provide a brief overview on CrowdStrike’s vision and opportunity, as well as deeper insights into the business.

Event:

CrowdStrike Investor Briefing

Location:

Virtual

Date:

Thursday, April 8, 2021

Presentation Time:

1:00 p.m. PT

A live webcast and replay of the briefing will be accessible from the investor relations section of CrowdStrike’s website ir.crowdstrike.com.

About CrowdStrike

CrowdStrike provides cloud-delivered endpoint and cloud workload protection. Leveraging artificial intelligence (AI), the CrowdStrike Falcon® platform protects customers against cyberattacks on endpoints and workloads on or off the network by offering visibility and protection across the enterprise.

© 2021 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon® are among the trademarks of CrowdStrike, Inc.

Investor Relations

CrowdStrike Holdings, Inc.

Maria Riley

[email protected]

669-721-0742

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Data Management Security Technology Software Networks Internet

MEDIA:

Logo
Logo
Posted on

Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution

NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “Science Drives Surging Interest in Psychedelic Therapeutics.”

To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

To view the full editorial, please visit: https://nnw.fm/3IBl7

Psilocybins are a hallucinogenic substance found in certain types of mushroom, dubbed magic mushrooms, and used for centuries by indigenous cultures for religious, spiritual and health-related purposes. As is often the case, the modern world is learning from the ancient as mounting evidence points to these prolific fungi as a source for long-sought-for help in mental health and neurological disorders.



Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF


) is intent on becoming the leader in this exciting breakthrough for mental well-being. The company is at the forefront of the revolution in mental health therapeutics and is developing a new class of psychedelic medicines and treatment protocols. Driving its commitment to excellence is the company’s impressive leadership team of experienced professionals with a combined 80-plus years in the pharmaceutical industry.

About Cybin
 
Inc.

Cybin is a mushroom life-science company advancing psychedelic and nutraceutical-based products. The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the company is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships. For more information about the company, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at http://nnw.fm/Cybin

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork



Posted on

Gilead Sciences Appoints Flavius Martin, MD as Executive Vice President, Research

Gilead Sciences Appoints Flavius Martin, MD as Executive Vice President, Research

– William (“Bill”) Lee, PhD to Retire After 30 Years at Gilead –

FOSTER CITY, Calif.–(BUSINESS WIRE)–
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Flavius Martin, MD will join the company as Executive Vice President, Research, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day. Dr. Martin will assume responsibility for Gilead’s research organization effective April 12, 2021. Bill Lee, PhD, is retiring from Gilead after three decades.

Dr. Martin brings to his new role significant experience overseeing industry-leading research, with particular expertise in oncology and inflammation. He joins Gilead from Amgen, Inc., where he most recently served as Vice President, Research Biology, leading discovery for Oncology, Inflammation and Cardiometabolic Research. He was also the site-head for Amgen South San Francisco. Prior to Amgen, Dr. Martin worked as a scientist and leader at Genentech, Inc.

“Flavius brings decades of experience in early drug discovery research and identification of promising therapeutic candidates,” said Mr. O’Day. “He has deep scientific expertise across therapeutic areas and has led the creation of high-quality portfolios in prior roles. I am delighted to welcome him to Gilead as we continue to expand and diversify our portfolio of new medicines.”

Dr. Martin received his MD at the University of Medicine and Pharmacy Timisoara, Romania. He completed his postdoctoral training at the University of Alabama at Birmingham in the Division of Developmental and Clinical Immunology. He has published numerous papers on the role of immune cells in driving inflammatory diseases and cancer, and holds a number of patents related to his discoveries.

“Gilead has outstanding research and clinical development programs across Virology, Immunology and Oncology, and I am tremendously excited to be joining an organization with such a deep and talented scientific core,” commented Dr. Martin. “Throughout my career, I have been focused on translating scientific discoveries into the development of potential new therapies with the goal of helping people with unmet medical needs. I look forward to pursuing this mission together with the talented team at Gilead.”

Dr. Lee joined Gilead in 1991. Over his 30-year career with the company, he has overseen research programs across multiple therapeutic areas and has led the advancement of numerous therapies from early-stage research into clinical development. His expertise contributed to the discovery of medicines and the identification of external partnerships.

“Bill’s contributions over three decades have allowed Gilead to bring important new medicines to patients around the world,” said Mr. O’Day. “I am grateful to Bill for the high bar he has set for Gilead’s research organization and the commitment he demonstrated pursuing scientific advancements that transformed care for people with serious diseases.”

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Jacquie Ross, Investors

(650) 358-1054

Marni Kottle, Media

(650) 522-5388

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Medical Supplies General Health Health Hospitals

MEDIA:

Logo
Logo
Posted on

Greenlight Re Innovations Announces Investment in SME-focused Credit Insurance Start-up Nimbla

GRAND CAYMAN, Cayman Islands, March 26, 2021 (GLOBE NEWSWIRE) — Greenlight Re Innovations (“GRI”), part of Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (“Greenlight Re” or the “Company”), a specialist property and casualty reinsurance company headquartered in the Cayman Islands, has announced an investment in TradeCrediTech Ltd. (“Nimbla”), a digital managing general underwriter focusing on the small and medium-sized enterprise (SME) credit insurance market.

Based in London, Nimbla is a technology-centric, highly automated MGA that has API integration capabilities to plug into the vast number of SME financing platforms that exist today. Due to these integrations, Nimbla can offer the immediate quote and bind of credit insurance at a single invoice level and address the underserved SME market within existing workflows. By analyzing a SME’s credit risk in real-time, Nimbla can dynamically price the insurance to reflect the current credit risk of a SME more accurately.

Simon Burton, Chief Executive Officer at Greenlight Re said, “In the current challenging economic environment, trade credit insurance offers valuable protection to businesses. The traditional trade credit underwriting process is cumbersome and Nimbla’s technology has introduced a new level of pricing speed and accuracy to trade credit insurance.”

Elizabeth Jenkin, Chief Commercial Officer at Nimbla said, “Nimbla has turned traditional trade credit insurance on its head with single invoice insurance; quote and bind in less than two minutes which significantly disrupts the traditional model. The partnership with Greenlight enables us to widen our reach geographically and build and distribute more complementary products, particularly during this challenging time for businesses. We recently added the ability to insure against credit risks in mainland Europe, responding to the demand from our customers. We have also launched our new API which enables funders to make ‘in the moment’ credit wrapped decisions. This speed and agility are trademarks of Nimbla and our partnership with Greenlight enables us to continue to innovate and be market makers rather than followers.”

Nimbla represents the thirteenth strategic investment made by GRI.

About Greenlight Capital Re, Ltd.

Established in 2004, Greenlight Re (www.greenlightre.ky) is a NASDAQ listed company with specialist property and casualty reinsurance companies based in the Cayman Islands and Ireland. Greenlight Re provides risk management products and services to the insurance, reinsurance, and other risk marketplaces. The Company focuses on delivering risk solutions to clients and brokers by whom Greenlight Re’s expertise, analytics and customer service offerings are demanded. With an emphasis on deriving superior returns from both sides of the balance sheet, Greenlight Re manages its assets according to a value-oriented equity-focused strategy that supports the goal of long-term growth in book value per share.

About Greenlight Re Innovations

GRI was launched in March 2018. The unit supports technology innovators in the (re)insurance space by providing investment, risk capacity, and access to a broad insurance network. The unit consists of experienced actuaries, underwriters, and insurance executives with a deep understanding of (re)insurance and the ability to help startups navigate the complex insurance ecosystem.

About Nimbla

Based in London, Nimbla aims to bring the trade credit industry into the 21st century. Challenging traditional insurance models, the cover is flexible and adapts to fit the diversity of businesses that comprise the SME market. Backed by expert risk analysts, Nimbla’s digital insurance platform allows businesses to check a buyer’s ability to pay and insure individual invoices against non-payment in a fast and affordable way. This capability enables business owners to safeguard against insolvent customers, expand into new and existing markets and secure better borrowing terms. For further information visit: www.nimbla.com.

Forward Looking Statements

This news release contains forward-looking statements within the meaning of the U.S. federal securities laws. The Company intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements made on behalf of the Company. These risks and uncertainties include the impact of general economic conditions and conditions affecting the insurance and reinsurance industry, the adequacy of our reserves, our ability to assess underwriting risk, trends in rates for property and casualty insurance and reinsurance, competition, investment market fluctuations, trends in insured and paid losses, catastrophes, regulatory and legal uncertainties and other factors described in the Company’s annual report on Form 10-K filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information contact:

Investor Relations

Adam Prior
The Equity Group Inc.
(212) 836-9606
[email protected]



Posted on

Gaia to Present at the Lytham Partners Spring 2021 Virtual Investor Conference on April 1, 2021

BOULDER, Colo., March 26, 2021 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, will be presenting at the Lytham Partners Spring 2021 Investor Conference, which is being held virtually on March 30–April 1, 2021.

Gaia is scheduled to present at 3:30 p.m. Eastern time on Thursday, April 1, 2021, with virtual one-on-one meetings held throughout the conference.

The presentation will be broadcast live and available for replay here and via the investor relations section of the company’s website at ir.gaia.com.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please contact your Lytham Partners representative or Gaia’s investor relations team at [email protected].

About Gaia

Gaia is a global video streaming service and community that provides curated conscious media in four primary channels—Seeking Truth, Transformation, Alternative Healing and Yoga—to its subscribers in 185 countries with approximately 8,000 titles. Over 85% of its library is exclusive to Gaia, and approximately 80% of the views are generated by content produced or owned by Gaia. For more information about Gaia, visit www.gaia.com.

Company Contact:

Paul Tarell
Chief Financial Officer
Gaia, Inc.
[email protected]

Investor Relations:

Gateway Investor Relations
Cody Slach
(949) 574-3860
[email protected]